ZIPALERTINIB

OncoDaily

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

May, 2025

ZIPALERTINIB

Feb 4, 2025, 10:31 | Insight

Stephen V Liu: The Phase 2b REZILIENT1 study of zipalertinib met its primary endpoint

Stephen V Liu, Associate Professor of Medicine at Georgetown University, Director of Thoracic Oncology and Head…

Dec 29, 2024, 10:00 | Drugs

Giannis Mountzios: 10 exciting compounds that will shape lung cancer in 2025

Giannis Mountzios, Consultant Medical Oncologist at the Department of Medical Oncology in the Air force…

All: 2 Posts: 1 - 100

'

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology

'

Richard Goldberg: Agenus Anticipates Interacting with FDA with New Data Coming at ESMO-GI 2025

'

USA vs Europe: Who Does Cancer Screening Better?

'

A Call for Peace from the Frontlines of Pediatric Oncology by the POEM Group

'

Servier Acquires Precision Therapy for Acute Leukemias from BioNova Pharmaceuticals

Special Coverage

Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023